Xiaomiao Cui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaomiao Cui has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Hui Wei
Nanjing University
4 shared publications - Qi Sun
Nanjing University
4 shared publications Wanling Liu
Nanjing University
3 shared publicationsDongze Mo
Nanjing University
2 shared publications- Hanjie Zhang
Nanjing University
2 shared publications Xiwen Chen
Nanjing University
2 shared publications
Latest Publications
- 10 November 2026
- Published by American Chemical Society (ACS) in ACS Nano
Biomimetic Nanozyme-Decoys Reprogram Immune Niches to Intercept Colitis-Carcinoma Transition
Colitis-associated colorectal cancer (CAC) arises from chronic inflammatory niches characterized by persistent oxidative stress and dysregulated immune cell recruitment. Current anti-inflammatory therapies provide only transient symptom relief and fail to prevent malignant progression due to their inability to simultaneously mitigate oxidative injury and immune chemotaxis. Our analysis of clinical samples revealed markedly elevated C-X-C motif chemokine ligand 2 (CXCL2) in intestinal tissues from patients with inflammatory bowel disease and CAC, implicating the CXCL2-CXCR2 (C-X-C motif chemokine receptor 2) axis in driving excessive neutrophil and macrophage infiltration and fostering tumorigenesis. Herein, we report a biomimetic nanozyme (PB@ECM) that reprograms inflammatory immune niches to intercept CAC progression. PB@ECM integrates a Prussian blue nanozyme core with genetically engineered macrophage membranes, enabling concurrent scavenging of reactive oxygen species through superoxide dismutase- and catalase-like activities and sequestration of CXCL2 via membrane-displayed CXCR2 receptors. In murine models of colitis and CAC, PB@ECM significantly alleviated intestinal inflammation, suppressed neutrophil and macrophage infiltration, and effectively inhibited colitis-carcinoma transition. Notably, treatment with PB@ECM significantly prolonged survival compared with other groups. By disrupting the pathological crosstalk between oxidative stress and immune chemotaxis, this work establishes a biomimetic nanozyme strategy for preventing inflammation-driven carcinogenesis.
- 10 November 2026
- Published by American Chemical Society (ACS) in ACS Nano
Biomimetic Nanozyme-Decoys Reprogram Immune Niches to Intercept Colitis-Carcinoma Transition
Colitis-associated colorectal cancer (CAC) arises from chronic inflammatory niches characterized by persistent oxidative stress and dysregulated immune cell recruitment. Current anti-inflammatory therapies provide only transient symptom relief and fail to prevent malignant progression due to their inability to simultaneously mitigate oxidative injury and immune chemotaxis. Our analysis of clinical samples revealed markedly elevated C-X-C motif chemokine ligand 2 (CXCL2) in intestinal tissues from patients with inflammatory bowel disease and CAC, implicating the CXCL2-CXCR2 (C-X-C motif chemokine receptor 2) axis in driving excessive neutrophil and macrophage infiltration and fostering tumorigenesis. Herein, we report a biomimetic nanozyme (PB@ECM) that reprograms inflammatory immune niches to intercept CAC progression. PB@ECM integrates a Prussian blue nanozyme core with genetically engineered macrophage membranes, enabling concurrent scavenging of reactive oxygen species through superoxide dismutase- and catalase-like activities and sequestration of CXCL2 via membrane-displayed CXCR2 receptors. In murine models of colitis and CAC, PB@ECM significantly alleviated intestinal inflammation, suppressed neutrophil and macrophage infiltration, and effectively inhibited colitis-carcinoma transition. Notably, treatment with PB@ECM significantly prolonged survival compared with other groups. By disrupting the pathological crosstalk between oxidative stress and immune chemotaxis, this work establishes a biomimetic nanozyme strategy for preventing inflammation-driven carcinogenesis.
- 14 September 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (37) , 25841-25858
A Theranostic Nanozyme for Osteoarthritis Treatment and Glycosaminoglycan-Targeted Diagnosis of Cartilage Pathology
The lack of vascular and neural innervations in cartilage often results in poor drug delivery and penetration, compromising the efficacy of current therapeutics. To tackle this clinical challenge, we designed positively charged manganese-doped CeO2 nanozymes that combine reactive oxygen species (ROS)-scavenging activity with prolonged retention in the joint cavity by taking advantage of the negatively charged cartilage matrix. Integrating coarse-grained molecular dynamics simulations with experimental validation, we identified chondroitin sulfate as the key glycosaminoglycan responsible for mediating the retention of these positively charged nanozymes in the joint cavity. After intra-articular administration, manganese-doped CeO2 promoted cartilage defect repair and subchondral bone remodeling in a rat model within 4 weeks. In addition, benefiting from the multiple enzyme mimicking activity of nanozymes, the peroxidase-like activity of manganese-doped CeO2 was explored to develop a pathological assay to detect the state of cartilage repair. This study establishes an integrated framework combining theoretical modeling with experimental validation to elucidate intra-articular retention mechanisms. The framework enables the rational design of theranostic nanozymes that exploit disease-specific pathological features for both diagnosis and therapy.
- 14 September 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (37) , 25841-25858
A Theranostic Nanozyme for Osteoarthritis Treatment and Glycosaminoglycan-Targeted Diagnosis of Cartilage Pathology
The lack of vascular and neural innervations in cartilage often results in poor drug delivery and penetration, compromising the efficacy of current therapeutics. To tackle this clinical challenge, we designed positively charged manganese-doped CeO2 nanozymes that combine reactive oxygen species (ROS)-scavenging activity with prolonged retention in the joint cavity by taking advantage of the negatively charged cartilage matrix. Integrating coarse-grained molecular dynamics simulations with experimental validation, we identified chondroitin sulfate as the key glycosaminoglycan responsible for mediating the retention of these positively charged nanozymes in the joint cavity. After intra-articular administration, manganese-doped CeO2 promoted cartilage defect repair and subchondral bone remodeling in a rat model within 4 weeks. In addition, benefiting from the multiple enzyme mimicking activity of nanozymes, the peroxidase-like activity of manganese-doped CeO2 was explored to develop a pathological assay to detect the state of cartilage repair. This study establishes an integrated framework combining theoretical modeling with experimental validation to elucidate intra-articular retention mechanisms. The framework enables the rational design of theranostic nanozymes that exploit disease-specific pathological features for both diagnosis and therapy.
- 5 June 2026
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 26 (23) , 7708-7718
Metal–Polyphenol Network Confined Synthesis of Nanozymes with Programmable Oxygen Vacancies for UVB Photodamage Therapy
Conventional sunscreens block ultraviolet B (UVB) but fail to scavenge accumulated reactive oxygen species (ROS), causing severe photodamage. Herein, we develop a room-temperature, aqueous coordination strategy that assembles metal-polyphenol networks (MPNs) to confine in situ nucleation and growth of metal oxide nanozymes. Utilizing tannic acid coordinated ceria (CeO2-TA) as a model system, we achieve programmable regulation of surface oxygen vacancies (Ov) by adjusting the ligand-to-metal molar ratio. This process involves ligand-to-metal charge transfer (LMCT) mediated interfacial electron redistribution, resulting in significant enhancements in superoxide dismutase (SOD)- and catalase (CAT)-like activities. This "ligand-unit equivalence" design is universally applicable across diverse polyphenols, yielding highly dispersed and catalytically efficient nanozymes. In vivo, topical CeO2-TA profoundly scavenges UVB-induced ROS, mitigating acute skin inflammation and preserving the extracellular matrix against photoaging. This work establishes a universal and scalable method for the development of Ov engineered nanozymes and promotes their integration into next-generation topical sunscreens.
- 5 June 2026
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 26 (23) , 7708-7718
Metal–Polyphenol Network Confined Synthesis of Nanozymes with Programmable Oxygen Vacancies for UVB Photodamage Therapy
Conventional sunscreens block ultraviolet B (UVB) but fail to scavenge accumulated reactive oxygen species (ROS), causing severe photodamage. Herein, we develop a room-temperature, aqueous coordination strategy that assembles metal-polyphenol networks (MPNs) to confine in situ nucleation and growth of metal oxide nanozymes. Utilizing tannic acid coordinated ceria (CeO2-TA) as a model system, we achieve programmable regulation of surface oxygen vacancies (Ov) by adjusting the ligand-to-metal molar ratio. This process involves ligand-to-metal charge transfer (LMCT) mediated interfacial electron redistribution, resulting in significant enhancements in superoxide dismutase (SOD)- and catalase (CAT)-like activities. This "ligand-unit equivalence" design is universally applicable across diverse polyphenols, yielding highly dispersed and catalytically efficient nanozymes. In vivo, topical CeO2-TA profoundly scavenges UVB-induced ROS, mitigating acute skin inflammation and preserving the extracellular matrix against photoaging. This work establishes a universal and scalable method for the development of Ov engineered nanozymes and promotes their integration into next-generation topical sunscreens.
- Open Access
- 5 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (49) , eadz3713
An ultrasmall theranostic nanozyme for abdominal aortic aneurysm management and therapeutic efficacy monitoring
Abdominal aortic aneurysm (AAA) is a life-threatening condition lacking effective drug interventions, and its progression is difficult to predict, complicating early clinical management. Here, we present a reactive oxygen species–responsive theranostic nanozyme for AAA early intervention and efficacy monitoring, establishing a feedback loop between treatment and diagnostics. OZn, designed by encapsulating ultrasmall Prussian blue (SPBZn) within oxidation-sensitive dextran, targets aneurysm sites, where it responds to inflammatory microenvironments by releasing SPBZn. In vivo, SPBZn not only mitigated CaCl 2 -induced aneurysm expansion and AAA progression in rat models but also enabled noninvasive diagnostic monitoring via urinalysis due to its enzymatic activities and renal metabolism. This theranostic nanozyme dynamically regulated therapeutic efficacy and provided feedback on disease progression. By preventing vascular rupture through early intervention and enabling precise drug administration, this work highlights a transformative strategy for integrating diagnostics and therapy to improve AAA management and clinical outcomes.
- 5 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (49) , eadz3713
Open AccessAn ultrasmall theranostic nanozyme for abdominal aortic aneurysm management and therapeutic efficacy monitoring
Abdominal aortic aneurysm (AAA) is a life-threatening condition lacking effective drug interventions, and its progression is difficult to predict, complicating early clinical management. Here, we present a reactive oxygen species–responsive theranostic nanozyme for AAA early intervention and efficacy monitoring, establishing a feedback loop between treatment and diagnostics. OZn, designed by encapsulating ultrasmall Prussian blue (SPBZn) within oxidation-sensitive dextran, targets aneurysm sites, where it responds to inflammatory microenvironments by releasing SPBZn. In vivo, SPBZn not only mitigated CaCl 2 -induced aneurysm expansion and AAA progression in rat models but also enabled noninvasive diagnostic monitoring via urinalysis due to its enzymatic activities and renal metabolism. This theranostic nanozyme dynamically regulated therapeutic efficacy and provided feedback on disease progression. By preventing vascular rupture through early intervention and enabling precise drug administration, this work highlights a transformative strategy for integrating diagnostics and therapy to improve AAA management and clinical outcomes.
- 27 August 2023
- Published by Wiley in Advanced Functional Materials
- Vol. 33 (51)
Microenvironment‐Responsive Hydrogels with Detachable Skin Adhesion and Mild‐Temperature Photothermal Property for Chronic Wound Healing
Chronic wounds have emerged as a global healthcare burden that have inability to heal within an expected time frame owing to the complex pathophysiological microenvironment, bacterial infection, multidrug resistance, and fragile skin tissue. Tailored to the features of chronic wounds, a multifunctional hydrogel (GA) composed of ethylenediamine‐modified gelatin (Gela‐amino) and oxidized sodium alginate (Alg─CHO) is reported. The thermosensitivity of gelatin and Schiff base bonds endow GA hydrogels with physiological temperature‐enhanced nonirritating tissue adhesion and low‐temperature‐triggered nondestructive separation, beneficial for the management of vulnerable and sensitive wounds. In addition, GA hydrogels exhibit pH‐responsive degradation that adapt to the acidic wound microenvironment. Under near‐infrared (NIR) irradiation, DNase I enzyme and indocyanine green‐loaded GA hydrogels (DI@GA) efficiently eradicate drug‐resistant bacteria biofilm and subsequently exert an antibacterial effect attributed to the bioactity of GA hydrogels and mild‐temperature photothermal therapy (≈45 °C). Remarkably, DI@GA/NIR hydrogels accelerate diabetic wound recovery and skin regeneration by dispersing biofilm, killing bacteria, inhibiting inflammation, promoting collagen deposition, and improving angiogenesis. The advanced hydrogels without the addition of antibiotics are promising to act as skin‐friendly wound dressings for rescuing infectious and stalled chronic wounds.
- 27 August 2023
- Published by Wiley in Advanced Functional Materials
- Vol. 33 (51)
Microenvironment‐Responsive Hydrogels with Detachable Skin Adhesion and Mild‐Temperature Photothermal Property for Chronic Wound Healing
Chronic wounds have emerged as a global healthcare burden that have inability to heal within an expected time frame owing to the complex pathophysiological microenvironment, bacterial infection, multidrug resistance, and fragile skin tissue. Tailored to the features of chronic wounds, a multifunctional hydrogel (GA) composed of ethylenediamine‐modified gelatin (Gela‐amino) and oxidized sodium alginate (Alg─CHO) is reported. The thermosensitivity of gelatin and Schiff base bonds endow GA hydrogels with physiological temperature‐enhanced nonirritating tissue adhesion and low‐temperature‐triggered nondestructive separation, beneficial for the management of vulnerable and sensitive wounds. In addition, GA hydrogels exhibit pH‐responsive degradation that adapt to the acidic wound microenvironment. Under near‐infrared (NIR) irradiation, DNase I enzyme and indocyanine green‐loaded GA hydrogels (DI@GA) efficiently eradicate drug‐resistant bacteria biofilm and subsequently exert an antibacterial effect attributed to the bioactity of GA hydrogels and mild‐temperature photothermal therapy (≈45 °C). Remarkably, DI@GA/NIR hydrogels accelerate diabetic wound recovery and skin regeneration by dispersing biofilm, killing bacteria, inhibiting inflammation, promoting collagen deposition, and improving angiogenesis. The advanced hydrogels without the addition of antibiotics are promising to act as skin‐friendly wound dressings for rescuing infectious and stalled chronic wounds.
- Open Access
- 1 December 2022
- Published by KEAI Publishing in Supramolecular Materials
- Vol. 1
Multicompartment polymer capsules
- 1 December 2022
- Published by KEAI Publishing in Supramolecular Materials
- Vol. 1
Open AccessMulticompartment polymer capsules